The Union Health Ministry hereby prohibits the use of cold FDC Chlorpheniramine Maleate 2 mg and Phenylephrine Hydrochloride 5 mg per ml drops in children below the...
.png "Venus Remedies' Polymyxin B Gets US FDA QIDP Designation")
The United States Food and Drug Administration (US FDA) has designated Venus Remedies Limited, a Panchkula-based pharmaceutical company that specializes in critical care injectables, as a Qualified Infectious Disease Product (QIDP) for the....
India's pharmaceutical exports to the United States, which amount to nearly $10 billion each year, may face challenges as the US government has commenced an investigation
Amidst the ongoing difficulties in global commerce brought on by US-China tariffs, India's medical equipment industry is seeing a startling increase in imports. Citing the possibility of serious harm to the domestic economy, the Association of Indian
Johnson & Johnson's CEO has cautioned that any US tariffs on the pharmaceutical sector may result in medication shortages. The Trump administration has made it plain that it is considering utilizing the broad tariffs that were announced this month
 (1).png "Dr. Lal PathLabs Launches South Asia's First Advanced Amyloidosis Test")
A pioneer in diagnostic medicine, Dr. Lal PathLabs Limited (Dr. Lal PathLabs) has unveiled Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry, a ground-breaking test for precisely identifying various forms of amyloid....
The campaign that spreads ResolverRAT through phishing emails uses a remote access trojan and targets the healthcare and pharmaceutical sectors. These emails are written in...
The Indian pharmaceutical industry has approached the Drug Controller General of India (DCGI), filing a plea for relaxation of the...
The Authentication Solution Providers’ Association (ASPA) will organize an Open House event on April 24, 2025, at Anantara Downtown Dubai, starting 5:00 PM onwards aimed at protecting consumers, businesses, and economies from the growing threat of
A major industry shift occurs in India because the country faces growing advancements in preventable eye diseases. TeleMedC has announced its entry into the Indian market through a strategic business agreement with AND Healthcare Solutions, which ope
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
